Funder: National Institutes of Health (NIH)

Due Dates: October 16, 2024 (New) | November 16, 2024 (Renewal/Resubmission)

Funding Amounts: Up to $275,000 total direct costs over 2 years, with no more than $200,000 in any single year.

Summary: Supports discovery, design, synthesis, and preclinical testing of novel therapeutics for nervous system disorders, excluding clinical trials.

Key Information: Applications must focus on therapeutic discovery, not target identification or clinical development; clinical trials are not allowed.